Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.30.1 (
S1 nuclease
)
3,660
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
An
HLA-E
-specific oligonucleotide probe was used to study the expression of
HLA-E
. This probe detects two
HLA-E
transcripts, 1.8 and 2.7 kb in size, which are present in varying ratios in all tissues and cell lines investigated. We demonstrate that alternative poly(A) site usage accounts for the differential regulation of the two
HLA-E
mRNA species. Sequence analysis of three cDNA clones, representing the two transcripts of
HLA-E
, and of an
HLA-E
gene encoded by cosmid cd3.14, revealed identity of gene and cDNA in the 3' untranslated region.
S1 nuclease
protection assays confirmed that the two
HLA-E
transcripts are not alternative splicing products. Introduction of cd3.14, together with human beta 2 m into the murine myeloma cell line P3X63-Ag8.653, resulted in a cell surface expression of an HLA-class I heavy chain detectable by indirect immunofluorescence whereas transfection into the human beta 2m expressing mouse L cell line, J27 was negative with regard to cell surface expression. Cell surface labeling of transfectants and immunoprecipitation with a monomorphic HLA class I-specific antibody or an antibody against human beta 2m confirmed the presence of an
HLA-E
H chain on the cell surface. These results indicate that the
HLA-E
gene codes for a class I H chain that can be expressed on the cell surface.
...
PMID:The HLA-E gene encodes two differentially regulated transcripts and a cell surface protein. 140 23